Benveniste O, Hogrel J-Y, Annoussamy M, et al. Rapamycin Vs. Placebo for the Treatment of Inclusion Body Myositis: Improvement of the 6 Min Walking Distance, a Functional Scale, the FVC and Muscle Quantitative MRI. ACR 2017, abstract 5L.
Nieuwe EULAR- en GRAPPA-richtlijnen voor PsA: zoek de verschillen
feb 2017 | Arthritis psoriatica